DrugPatentWatch Database Preview
PF PRISM CV Company Profile
What is the competitive landscape for PF PRISM CV, and when can generic versions of PF PRISM CV drugs launch?
PF PRISM CV has seventeen approved drugs.
There are forty-eight US patents protecting PF PRISM CV drugs.
There are one thousand one hundred and ten patent family members on PF PRISM CV drugs in seventy-seven countries and eighty supplementary protection certificates in fifteen countries.
Summary for PF PRISM CV
| International Patents: | 1110 |
| US Patents: | 48 |
| Tradenames: | 13 |
| Ingredients: | 12 |
| NDAs: | 17 |
Drugs and US Patents for PF PRISM CV
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pf Prism Cv | CHANTIX | varenicline tartrate | TABLET;ORAL | 021928-001 | May 10, 2006 | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Pf Prism Cv | TYGACIL | tigecycline | POWDER;INTRAVENOUS | 021821-001 | Jun 15, 2005 | AP | RX | Yes | Yes | 7,879,828 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | ||
| Pf Prism Cv | LYRICA | pregabalin | CAPSULE;ORAL | 021446-007 | Dec 30, 2004 | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Pf Prism Cv | XELJANZ | tofacitinib citrate | TABLET;ORAL | 203214-002 | May 30, 2018 | RX | Yes | Yes | 6,956,041 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for PF PRISM CV
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Pf Prism Cv | VFEND | voriconazole | TABLET;ORAL | 021266-001 | May 24, 2002 | 5,773,443 | ➤ Try a Free Trial |
| Pf Prism Cv | VFEND | voriconazole | INJECTABLE;IV (INFUSION) | 021267-001 | May 24, 2002 | 5,364,938 | ➤ Try a Free Trial |
| Pf Prism Cv | RAPAMUNE | sirolimus | TABLET;ORAL | 021110-003 | Feb 23, 2004 | 5,403,833*PED | ➤ Try a Free Trial |
| Pf Prism Cv | TYGACIL | tigecycline | POWDER;INTRAVENOUS | 021821-001 | Jun 15, 2005 | 5,494,903 | ➤ Try a Free Trial |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Paragraph IV (Patent) Challenges for PF PRISM CV drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Oral Solution | 20 mg/mL | ➤ Subscribe | 2010-05-19 |
| ➤ Subscribe | Tablets | 1 mg and 5 mg | ➤ Subscribe | 2018-02-23 |
| ➤ Subscribe | Tablets | 50 mg and 200 mg | ➤ Subscribe | 2008-04-14 |
| ➤ Subscribe | For Injection | 50 mg per vial | ➤ Subscribe | 2009-06-15 |
| ➤ Subscribe | Tablets | 1 mg and 2 mg | ➤ Subscribe | 2009-12-17 |
| ➤ Subscribe | Extended-release Tablets | 330 mg | ➤ Subscribe | 2018-01-29 |
| ➤ Subscribe | Extended-release Tablets | 330 mg | ➤ Subscribe | 2018-01-29 |
| ➤ Subscribe | Extended-release Tablets | 50 mg and 100 mg | ➤ Subscribe | 2012-02-29 |
| ➤ Subscribe | Tablets | 100mg and 500mg | ➤ Subscribe | 2016-09-06 |
| ➤ Subscribe | Capsules | 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg and 300 mg | ➤ Subscribe | 2008-12-30 |
| ➤ Subscribe | Tablets | 0.5 mg and 1 mg | ➤ Subscribe | 2010-05-10 |
| ➤ Subscribe | For Injection | 200 mg/vial | ➤ Subscribe | 2008-09-12 |
| ➤ Subscribe | Tablets | 5 mg | ➤ Subscribe | 2016-11-07 |
| ➤ Subscribe | Oral Suspension | 40 mg/mL | ➤ Subscribe | 2010-10-08 |
| ➤ Subscribe | Injection | 25 mg/mL, 1.8 mL vial | ➤ Subscribe | 2011-05-25 |
| ➤ Subscribe | Tablets | 0.5 mg | ➤ Subscribe | 2010-08-25 |
| ➤ Subscribe | Extended-release Tablets | 82.5 mg and 165 mg | ➤ Subscribe | 2018-02-02 |
| ➤ Subscribe | Extended-release Tablets | 82.5 mg and 165 mg | ➤ Subscribe | 2018-02-02 |
| ➤ Subscribe | Extended-release Tablets | 25 mg | ➤ Subscribe | 2015-05-08 |
| ➤ Subscribe | Tablets | 400 mg | ➤ Subscribe | 2018-10-15 |
International Patents for PF PRISM CV Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Spain | 2165857 | ➤ Try a Free Trial |
| Mexico | PA04009424 | ➤ Try a Free Trial |
| Mexico | 2008000384 | ➤ Try a Free Trial |
| African Intellectual Property Organization (OAPI) | 12118 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for PF PRISM CV Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 2008000023 | Germany | ➤ Try a Free Trial | PRODUCT NAME: TEMSIROLIMUS ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON; REGISTRATION NO/DATE: EU/1/07/424/001 20071119 |
| 5 | Finland | ➤ Try a Free Trial | |
| 00587 | Netherlands | ➤ Try a Free Trial | PRODUCT NAME: CRIZOTINIB, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, HYDRAAT OF SOLVAAT; REGISTRATION NO/DATE: EU/1/12/793/001-004 20121023 |
| /2008 | Austria | ➤ Try a Free Trial | PRODUCT NAME: TEMSIROLIMUS ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON; REGISTRATION NO/DATE: EU/1/07/424/001 20071119 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
